De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET. (Record no. 27343365)

MARC details
000 -LEADER
fixed length control field 02662 a2200613 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517162740.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201709s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1527-7755
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1200/JCO.2016.71.9815
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Harbeck, Nadia
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170915
245 00 - TITLE STATEMENT
Title De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Date of publication, distribution, etc. Sep 2017
300 ## - PHYSICAL DESCRIPTION
Extent 3046-3054 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ado-Trastuzumab Emtansine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers, Tumor
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maytansine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoadjuvant Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Precision Medicine
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, ErbB-2
General subdivision biosynthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Trastuzumab
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gluz, Oleg
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Christgen, Matthias
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kates, Ronald Ernest
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Braun, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Küemmel, Sherko
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schumacher, Claudia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Potenberg, Jochem
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kraemer, Stefan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kleine-Tebbe, Anke
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Augustin, Doris
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aktas, Bahriye
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Forstbauer, Helmut
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tio, Joke
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name von Schumann, Raquel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liedtke, Cornelia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Grischke, Eva-Maria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schumacher, Johannes
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wuerstlein, Rachel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kreipe, Hans Heinrich
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nitz, Ulrike Anneliese
773 0# - HOST ITEM ENTRY
Title Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Related parts vol. 35
-- no. 26
-- p. 3046-3054
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1200/JCO.2016.71.9815">https://doi.org/10.1200/JCO.2016.71.9815</a>
Public note Available from publisher's website

No items available.